סיטפורמין ויטאמד 50מ"ג/850 מ"ג - Sitaformin vitamed 50 mg/850 mg
× ×ª×× × ×ª×¨×פ×
×××¨×©× 
| ××× ×× ×× × ×ספ×× | |
|---|---|
| ×§×××¦× ×¤×¨××§×××××ת (ATC4) | A10BD Combinations of oral blood glucose lowering drugs |
| ×ר××× ×¤×¢×× (ATC5) | Â
|
| צ×רת ××ª× | פ××× - PER OS |
| צ×רת ××× ×× | ×××××ת ×צ×פ×ת פ×××, FILM COATED TABLETS ××× ×עת ××× ×× ×תר ×× ×רע×× ×ש ××××× ×ת ×תר××¤× ××ת×× ×××× ×× ××××××¥ ××¤× ×©××פ××¢ ××¢××× ×צר×× |
| ×ת×××× | SITAFORMIN VITAMED is indicated as an adjunct to diet and exerise to improve glycemic control in adult patients with type 2 diabetes mellitus. Important limitations of use: SITAFORMIN VITAMED should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis, as it would not be effective in these settings. SITAFORMIN VITAMED has not been studied in patients with a history of pancreatitis. It is unkown whether patients with a history of pancreatitis are at risk for the development of pancreatitis while using SITAFORMIN VITAMED. |
| ×¢××× ×ר××¤× ××××ר×ת ××¢××× |
 ××× ×¢××× ×ר××¤× Â |
| ×¢××× ×צר×× |  |
|---|
| ער××× ×××××§×רפ××× | ער××× ×§×©×ר×× ×××××§×רפ××× |
|---|---|
| ס××פ×ר××× ×××××× 50×"×/850 ×"× ××××ר ××©×¨× ××ר×××ת |
| ××פ×ש ×××ר×× | ×××ר×× ×-PubMed |
|---|---|
| ××××¢ ×רשת | RxList WebMD Drugs.com |
| ×©× ××¦×¨× | GALENICUM HEALTH, S.L., SPAIN |
| ×©× ××¢× ×ר×ש×× | VITAMED PHARMACEUTICAL INDUSTRIES LTD |
| ר×ש××× | ת×ר×× ××ש×: 10/2021. ר×ש××× ×ת×ר××: |
| ת×ר×× ×¢×××× ××ר×× | 13/05/2025 |
השינוי האחרון נעשה בֹ־13 במאי 2025 ב־11:17